Wan-Fen Li

1.1k total citations
25 papers, 811 citations indexed

About

Wan-Fen Li is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Wan-Fen Li has authored 25 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Health, Toxicology and Mutagenesis, 7 papers in Molecular Biology and 6 papers in Nutrition and Dietetics. Recurrent topics in Wan-Fen Li's work include Heavy Metal Exposure and Toxicity (9 papers), Paraoxonase enzyme and polymorphisms (5 papers) and Arsenic contamination and mitigation (5 papers). Wan-Fen Li is often cited by papers focused on Heavy Metal Exposure and Toxicity (9 papers), Paraoxonase enzyme and polymorphisms (5 papers) and Arsenic contamination and mitigation (5 papers). Wan-Fen Li collaborates with scholars based in Taiwan, United States and Australia. Wan-Fen Li's co-authors include Shu‐Li Wang, Saou-Hsing Liou, Chien‐Jen Chen, Clement E. Furlong, Rebecca J. Richter, Diana M. Shih, Aldon J. Lusis, Lucio G. Costa, Aaron D. Tward and Jein-Wen Chen and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Cancer Research.

In The Last Decade

Wan-Fen Li

24 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wan-Fen Li Taiwan	13	380	214	172	166	138	25	811
Gaolong Zhong China	17	282 0.7×	13 0.1×	165 1.0×	63 0.4×	279 2.0×	41	892
Yong‐Dae Kim South Korea	19	371 1.0×	28 0.1×	25 0.1×	36 0.2×	94 0.7×	74	888
Balázs Németi Hungary	16	191 0.5×	24 0.1×	347 2.0×	65 0.4×	106 0.8×	23	691
Yusong Ding China	19	120 0.3×	16 0.1×	114 0.7×	59 0.4×	174 1.3×	61	1.1k
Patrick F. Miller United Kingdom	13	315 0.8×	23 0.1×	37 0.2×	65 0.4×	151 1.1×	17	838
Tania Ruíz-Vera Mexico	15	295 0.8×	32 0.1×	42 0.2×	25 0.2×	41 0.3×	24	467
Mojtaba Kalantar Iran	16	85 0.2×	16 0.1×	46 0.3×	109 0.7×	55 0.4×	56	796
Chun Fa Huang Taiwan	8	403 1.1×	10 0.0×	100 0.6×	61 0.4×	192 1.4×	10	703
Pritha Bhattacharjee India	19	381 1.0×	13 0.1×	463 2.7×	80 0.5×	111 0.8×	50	1.1k
Carmen González‐Horta Mexico	15	330 0.9×	8 0.0×	286 1.7×	72 0.4×	61 0.4×	40	797

Countries citing papers authored by Wan-Fen Li

Since Specialization

Citations

This map shows the geographic impact of Wan-Fen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan-Fen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan-Fen Li more than expected).

Fields of papers citing papers by Wan-Fen Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan-Fen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan-Fen Li. The network helps show where Wan-Fen Li may publish in the future.

Co-authorship network of co-authors of Wan-Fen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wan-Fen Li. A scholar is included among the top collaborators of Wan-Fen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan-Fen Li. Wan-Fen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Ting‐Yu, et al.. (2025). Preclinical evaluation of a novel antibody–drug conjugate OBI-992 for Cancer therapy. Scientific Reports. 15(1). 8735–8735. 2 indexed citations

Shia, Chi‐Sheng, et al.. (2024). Abstract 7179: OBI-992, a novel TROP2 targeting antibody drug conjugate demonstrates superior in vivo PK/PD properties and a favorable safety profile. Cancer Research. 84(6_Supplement). 7179–7179. 1 indexed citations

Li, Wan-Fen, et al.. (2024). OBI-992, a Novel TROP2-Targeted Antibody–Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models. Molecular Cancer Therapeutics. 24(2). 163–175. 6 indexed citations

Huang, Teng‐Yi, et al.. (2024). Abstract 3149: Development of a novel site-specific ADC glycan platform with potential for improved in vivo efficacy and stability of the ADC in animal studies. Cancer Research. 84(6_Supplement). 3149–3149. 1 indexed citations

Chen, Chuying, Yin‐Cheng Hsieh, Yichen Wu, et al.. (2023). Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. PLoS ONE. 18(3). e0283473–e0283473. 5 indexed citations

Shia, Chi‐Sheng, Wan-Fen Li, I‐Ju Chen, et al.. (2021). Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug Conjugate. Molecular Cancer Therapeutics. 20(6). 1121–1132. 23 indexed citations

Li, Wan-Fen, et al.. (2021). Production of Pyracantha Polysaccharide-Iron(III) Complex and Its Biologic Activity. Molecules. 26(7). 1949–1949. 12 indexed citations

Chen, Yu‐Jung, et al.. (2019). Abstract 4815: Novel Globo H targeting antibody-drug conjugate with binding specificity and anti-tumor efficacy in multiple cancer types. Cancer Research. 79(13_Supplement). 4815–4815. 2 indexed citations

Liao, Hui-Yi, Yu-Teh Chung, Ching‐Huang Lai, et al.. (2013). Six-month follow-up study of health markers of nanomaterials among workers handling engineered nanomaterials. Nanotoxicology. 8(sup1). 100–110. 86 indexed citations

10.

Chen, Chien‐Jen, Wan-Fen Li, Ling‐I Hsu, et al.. (2012). Elevated lactate dehydrogenase activity and increased cardiovascular mortality in the arsenic-endemic areas of southwestern Taiwan. Toxicology and Applied Pharmacology. 262(3). 232–237. 27 indexed citations

11.

Liou, Saou-Hsing, Tsui‐Chun Tsou, Shu‐Li Wang, et al.. (2012). Epidemiological study of health hazards among workers handling engineered nanomaterials. Journal of Nanoparticle Research. 14(8). 59 indexed citations

12.

Chen, Jein-Wen, Hsiao-Yen Chen, Wan-Fen Li, et al.. (2011). The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan. Chemosphere. 84(1). 17–24. 71 indexed citations

13.

Li, Wan-Fen, Chien-Wen Sun, Tain‐Junn Cheng, et al.. (2009). Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. Toxicology and Applied Pharmacology. 236(2). 246–253. 32 indexed citations

14.

Chiu, Yu‐Wen, et al.. (2009). The Association of Metallothionein-4 Gene Polymorphism and Renal Function in Long-Term Lead-Exposed Workers. Biological Trace Element Research. 137(1). 55–62. 22 indexed citations

15.

Chiu, Yu‐Wen, et al.. (2009). Increased concentrations of serum inhibin B among male workers with long-term moderate lead exposure. The Science of The Total Environment. 407(8). 2603–2607. 3 indexed citations

16.

Li, Wan-Fen, Chien‐Jen Chen, Ronald J. Prineas, et al.. (2008). Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality. Toxicology and Applied Pharmacology. 239(2). 178–183. 11 indexed citations

17.

Wang, Shu‐Li, Feng-Hsiang Chang, Saou-Hsing Liou, et al.. (2007). Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environment International. 33(6). 805–811. 85 indexed citations

18.

Li, Wan-Fen & Hung‐Yi Chuang. (2007). Copper Deficiency, Lead, and Paraoxonase: Li et al. Respond. Environmental Health Perspectives. 115(7). 1 indexed citations

19.

Li, Wan-Fen, et al.. (2006). Lead Exposure Is Associated with Decreased Serum Paraoxonase 1 (PON1) Activityand Genotypes. Environmental Health Perspectives. 114(8). 1233–1236. 48 indexed citations

20.

Li, Wan-Fen, Lucio G. Costa, Rebecca J. Richter, et al.. (2000). Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics. 10(9). 767–779. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact